Dr. Anthony Chan is a pediatric hematologist/oncologist at Hamilton Health Sciences and a Professor of Pediatrics at McMaster University. He currently holds the McMaster Children’s Hospital/Hamilton Health Sciences Foundation Chair in Pediatric Thrombosis and Hemostasis (third term). He is the Director of the Pediatric Thrombosis Clinic and Hemophilia Clinic at McMaster Children’s Hospital and is a clinical scientist with the Thrombosis & Atherosclerosis Research Institute (TaARI) and David Braley Cardiac, Vascular and Stroke Research Institute (DBCVSRI).

Dr. Chan is considered to be one of the leading experts in the field of pediatric thrombosis and stroke. He is involved in designing clinical studies in pediatric thrombosis, pediatric stroke and hemophilia from a hematology perspective. His research focus is on the development, characterization and application of a covalent antithrombin-heparin complex (ATH), a potent anticoagulant that can be used as a systemic drug or can be grafted onto the surface of medical devices to render them non-thrombogenic. He is continuing to contribute his expertise in thrombosis by providing around-the-clock free consultation worldwide through the 1800NOCLOTS service. He was awarded the Order of Ontario (2017) for his work in advancing the care of children with thrombosis and stroke. Dr. Chan was inducted into the Canadian Academy of Health Science in 2022 recognizing his contribution to child health through research and clinical services and was the recipient of the Ann Harrington Award (2023) from Hemophilia Ontario for his contribution to patient care, leadership, and education in hemophilia.